Survey: Biopharma still reliant on paper, email for sharing TMFs

A survey by Veeva Systems ($VEEV) found biopharma companies still use paper or simple electronic systems to manage trial master files (TMFs). Paper and email are the primary means of sharing files with CROs, sites and regulators, despite the likes of Veeva talking up the benefits of using electronic TMF applications. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.

Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.